Has Craig Richman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,945 in general payments to Craig Richman, MD across 112 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Craig Richman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Craig Richman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Craig Richman, MD

Otolaryngology · Dunwoody, GANPI 1902806284

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 30.9% of the total. 2025 is the largest year on record at $1,065, 2.8 times the $382 reported in 2019.

$2,945in general payments, 2019–2025

Across 112 payments — averaging $26.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$910
Regeneron Healthcare Solutions, Inc.$394
AstraZeneca$203
GSK$199
Sanofi$184
Merck$168
plus $887 from 16 others

What the payments were for

Food & beverage$2,945100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	29	$910
Regeneron Healthcare Solutions, Inc.	17	$394
AstraZeneca	5	$203
GSK	15	$199
Sanofi	4	$184
Merck	10	$168
Integra Lifesciences Corporation	1	$150
Aerin Medical Inc.	1	$149
Hikma Pharmaceuticals USA	7	$103
Smith+Nephew	2	$85
Optinose US, Inc.	4	$76
Amgen	4	$71
ARS Pharmaceuticals Operations, Inc.	2	$57
Johnson & Johnson	2	$36
Kaleo, Inc.	2	$32
Medtronic	1	$25
Olympus America Inc.	1	$21
Taiho Oncology, Inc.	1	$19
KARL Storz Endoscopy-america	1	$17
Myriad Genetic Laboratories, Inc.	1	$17
Karyopharm Therapeutics Inc.	1	$16
Eisai Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Acclarent Aera$150
Inspira Air$150
RELIEVA SPINPLUS NAV$150
TruDi Probe$150
VIVAER STYLUS$149
RHINAER STYLUS$149
Inspire Upper Airway Stimulation System$136
DUPIXENT$122
Inspire$120

How this compares

$2,945 in reported general payments places this provider in the 70th percentile of 308 otolaryngology providers in Georgia.

See all otolaryngology providers in Georgia →

Medicare billing

Part B allowed, 2024

$73,278

Medicare patients

248

Services billed

813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	79	$1,973
Fluticasone Propionate	96	$1,116
Ipratropium Bromide	46	$1,038
Cefdinir	13	$265
Omeprazole	47	$166
Esomeprazole Magnesium	18	$139
Methylprednisolone	14	$64
Prednisone	18	$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Dunwoody

Dozier HoodFayetteville$347K
Christopher MelroySavannah$298K
Karen HoffmannAtlanta$223K
Jose StolovitzkyAtlanta$81K
Jonathan LindmanEvans$55K
Gregory PostmaAugusta$37K
Oswaldo HenriquezSmyrna$15K
Donald BrowningLawrenceville$14K
Robert GadlageDuluth$14K
Lawrence WeissMarietta$9K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →